Literature DB >> 7823246

The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.

G Khan1, P J Coates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7823246     DOI: 10.1002/path.1711740302

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


× No keyword cloud information.
  6 in total

1.  Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.

Authors:  Toni Portis; Richard Longnecker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  An auto-regulatory loop for EBV LMP2A involves activation of Notch.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  Virology       Date:  2007-11-05       Impact factor: 3.616

3.  Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.

Authors:  Ryan Incrocci; Levi Barse; Amanda Stone; Sai Vagvala; Michael Montesano; Vijay Subramaniam; Michelle Swanson-Mungerson
Journal:  Virology       Date:  2016-10-25       Impact factor: 3.616

Review 4.  The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.

Authors:  M Weinreb; P J Day; F Niggli; J E Powell; F Raafat; P B Hesseling; J W Schneider; P S Hartley; F Tzortzatou-Stathopoulou; E R Khalek; A Mangoud; U R El-Safy; F Madanat; M Al Sheyyab; C Mpofu; T Revesz; R Rafii; K Tiedemann; K D Waters; J C Barrantes; A Nyongo; M S Riyat; J R Mann
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

5.  Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.

Authors:  G Khan; M A Naase
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

6.  Seasonal variations in the onset of childhood leukaemia and lymphoma.

Authors:  R M Westerbeek; V Blair; O B Eden; A M Kelsey; R F Stevens; A M Will; G M Taylor; J M Birch
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.